Neurochemical aspects on aging and diseases with cognitive impairment
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The concentrations of monoamines and cholineacetyl transferase (CAT) are reduced in brains from patients with normal aging. According to findings about the dopamine (DA) system, the age‐sensitive decrease has its onset in the 60s and after that has a continuous progress. In patients with Alzheimer's disease (AD/SDAT), multiple changes indicate disturbed metabolism in the acetylcholine (ACh), DA, noradrenaline (NA), and 5‐hydroxytryptamine (5‐HT) systems. The activity of monoamine oxidase B (MAO‐B) increases significantly with age and a further‐increase has been reported to occur in Alzheimer‐afflicted brains. In the platelets, too, there is increased MAO‐B activity in AD/SDAT patients. Increased enzyme activity is considered a marker of gliosis in the brain and a marker of macrocytosis in platelets. Gangliosides are reduced in several areas of the brain in AD/SDAT patients, which indicates a reduction of nerve terminals. Significantly reduced concentrations of myelin components have also been recorded in brains from patients with AD/SDAT, which is in agreement with histopathological findings. The neurochemical changes recorded in brains from normally aged individuals are very similar to those found in AD/SDAT brains, although the latter changes are more‐severe. Thus, it has been suggested that the pathological process in AD/SDAT may be an exacerbation of the process taking place in normal aging. The multiple neurochemical changes recorded in grey, as well as in white matter must still be considered changes of secondary nature. At the present level of knowledge, it is not possible to single out any one of these changes as of special etiological importance. In the brains of patients with AD/SDAT, more fundamental disturbances must be considered, the nature of which we still do not know. It should also be emphasized that the pathological changes in the central nervous system reported in patients with AD/SDAT have, to some extent, also been found outside the brain, indicating that the pathological process in AD/SDAT is a general process to which the central nervous system is possibly especially sensitive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545 · cited 1×
“Impaired cholinergic function seems to play an important role for memory and cognitive deficits in normal aging (Bartus et al., 1982).”
BackgroundAlzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627 · cited 1×
“The neurochemical data are supported by a large number of histological studies in which a reduced number of neurons have been reported in the medial forebrain nucleus basalis of Meynert (Whitehouse et al., 1982; Arendt et al., 1983).”
BackgroundDavies, P., Katzman, R., & Terry, R. D. (1980) · Nature · doi:10.1038/288279a0 · Cited by 882 · cited 1×
“Somatostatin-like immunoreactivity (S) in brain tissue from patients with ADiSDAT has shown a generalized decrease in many brain regions (Davies et al., 1980; Rossor et al., 1980; Davies and Terry, 1981; for a review, see Hardy et a]., 1985; and Cowburn et al., 1989).”
BackgroundLoss of Dopamine Uptake Sites Labeled with [ 3 H]GBR-12935 in Alzheimer’s Disease
Allard, P., Alafuzoff, I., Carlsson, A., Eriksson, K., Ericson, E., Gottfries, C.-G., & Marcusson, J. O. (2008) · European Neurology · doi:10.1159/000117341 · Cited by 64 · cited 1×
“In basal ganglia, both DA and HVA are significantly reduced in AD/SDAT patients (for a review, see Mann et a]., 1987; Gottfries, 1988; Cowburn et al., 1989; Allard et al., 1990).”
BackgroundSelf-citation
Cited by
Motor control and aging: Links to age-related brain structural, functional, and biochemical effects
Seidler, R. D., Bernard, J. A., Burutolu, T. B., Fling, B. W., Gordon, M. T., Gwin, J. T., Kwak, Y., & Lipps, D. B. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.10.005 · Cited by 1,791
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Meltzer, M. D. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00194-2 · Cited by 517
Connor, J. R., Snyder, B. S., Beard, J. L., Fine, R. E., & Mufson, E. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310214 · Cited by 374
“Such a loss of white matter in AD has been reported and the loss is attributed to an insufficient nutritional supply to oligodendrocytes (Gottfries, 1990).”
BackgroundOrigins of depression in later life
BLAZER, D. G., & HYBELS, C. F. (2005) · Psychological Medicine · doi:10.1017/s0033291705004411 · Cited by 347
“CRF, however, is also diminished with normal aging (Gottfries, 1990).”
Background
Metadata
- Authors
- Gottfries, C. G.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 1990-12
- Volume
- 27
- Issue
- 4
- Pages
- 541-547
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2050504609
- Cited by
- 107
- References
- 4
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurochemical aspects on aging and diseases with cognitive impairment. https://app.cochat.ai/papers/10.1002/jnr.490270415
- The paper
- Gottfries, C. G. (1990). Neurochemical aspects on aging and diseases with cognitive impairment. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.490270415
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.